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Objective: to investigate the evidence available in the literature on non-adherence to 
immunosuppressive therapy among patients undergoing liver transplantation. Method: integrative 
literature review, including research whose sample consisted of patients aged over 18 years 
undergoing liver transplantation. It excluded those containing patients undergoing multiple organ 
transplants. For the selection of articles, Medline / Pubmed, CINAHL, LILACS, Scopus and Embase 
were searched. The search period corresponded to the initial date of indexation of different bases, 
up to the deadline of February 10, 2015, using controlled and uncontrolled descriptors: liver 
transplantation, hepatic transplantation, liver orthotopic transplantation, medication adherence, 
medication non-adherence, medication compliance and patient compliance. Results: were 
located 191 investigations, 10 of which met the objectives of the study and were grouped into 
four categories, namely: educational process and non-adherence; non-adherence related to the 
number of daily doses of immunosuppressive medications; detection methods for non-adherence 
and side effects of therapy. Conclusion: there were risk factors related to the health service, such 
as control and reduction of the number of doses; related to the individual, such as being male, 
divorced, alcohol or other substances user, exposed to low social support and being mentally ill.
Descriptors: Liver Transplantation; Medication Adherence; Patient Compliance; Nursing.
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Introduction
Liver transplantation allows the patients with 
terminal liver disease the opportunity to increase their 
quality of life, coupled with increased survival. However, 
the results are closely linked to the daily commitment 
of the patient with their immunosuppressive therapy(1-3).
The graft receiver survival time may vary according 
to the initial diagnosis, ranging between 60 and 70% in 
the first five years, depending on the type of primary 
disease leading to the need of transplantation. It is worth 
noting that the procedure allows that approximately 
80% of patients resume their work activities(4).
It is clear that non-adherence to immunosuppressive 
therapy increases the risk of graft loss, in addition there 
is increased morbidity, represented by the presence of 
tremor, neurotoxicity, and acute renal failure and also 
the increase in mortality and re-hospitalization, raising 
the costs to the health system(3-5).
Thus, adherence to the treatment plan can be 
defined as the patients’ behavior, which meets the 
recommendations agreed with health professionals 
in relation to taking medicines, following the diet or 
changing their lifestyle(6-7 ).
Evaluation of adherence to drug therapy is a complex 
task. However, some methods have been proposed 
for their verification, ranging from questionnaires, 
measurement of serum drug dosage, or the counting 
of dispensed tablets; yet, it is noteworthy that none of 
these forms of assessment obtained greater sensitivity 
than 80%(8).
The non-adherence rates to immunosuppressive 
medications among patients receiving solid organs can 
range from 36% among kidney transplant; 14.5% of 
heart recipients and 6.7% of liver transplant recipients. 
A previous research has shown that one of every 10 
deaths from liver transplant patients is related to non-
adherence to immunosuppressant(8). On the other 
hand, a meta-analysis including 147 studies published 
between 1981 and 2005 addressed the adherence 
to immunosuppressive therapy following solid organ 
transplantation, and found that only 20% of these 
articles were related to liver recipients(9).
Nurse is the professional spending more time 
with the patient, so he is the most suitable for the 
development of educational activities. The result of 
these actions reflected in increased satisfaction and 
quality of life, the effective delivery of care at home, 
anxiety reduction, the empowerment of the individual 
against the disease process and an increased treatment 
adherence(10).
Thus, it is of great value to research the reasons 
that may contribute to non-adherence to treatment in 
the postoperative period, in order to support nursing 
actions with this group of patients.
Therefore, this study aimed to investigate 
evidence available in the literature on non-adherence to 
immunosuppressive therapy among patients undergoing 
liver transplantation.
Method
For the preparation of the integrative review (IR) 
the following steps were followed: identifying the topic 
and defining the guiding question; sampling or literature 
search; extraction of data from the included studies; 
evaluation of studies and interpretation of results, and 
finally, the knowledge synthesis or integrative review of 
the presentation itself(11).
For preparation the guiding question of the review, 
we used the PICO strategy(12), described in sequence 
(Figure 1).
P (patient) Patients submitted to liver transplant
I (intervention) Immunosuppressant therapy
C (control) (Not applicable)
O (outcome) Adherence to immunosuppressant therapy 
Figure 1 - PICO strategy adopted to build the guiding 
question for the integrative review. Sao Paulo, 2015
So the central question of this review consisted 
of: what factors indicated by the scientific literature, 
interfere with adherence in patients submitted to liver 
transplantation, to the therapy with immunosuppressant 
drugs?
The following inclusion criteria were: primary 
studies that included in the sample patients aged over 
18 years undergoing liver transplantation; published in 
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(Medline / Pubmed), Cumulative Index to Nursing 
and Allied Health Literature (CINAHL-Ebsco) and Latin 
American and Caribbean Health Sciences (LILACS), 
Scopus and Embase. In the selection of descriptors the 
terms used are those in the Medical Subject Headings 
(MeSH), in the List of Headings of CINAHL Information 
Systems and Descriptors in Health Sciences (DeCS) of 
the Virtual Health Library. The pre-determined search 
period corresponded to the initial date of indexation of 
the different databases, up to the deadline of February 
10, 2015.
Thus, considering the analyzed databases, the 
descriptors used are described in the table below (Figure 2).
Portuguese, English or Spanish. Exclusion criteria were: 
scientific articles that addressed the issue of adherence 
among patients undergoing other types of transplants or 
multiple organ transplants.
Regarding the guiding question, the controlled and 
non-controlled descriptors were: liver transplantation, 
hepatic transplantation, orthotopic liver transplantation, 
medication adherence, medication non-adherence, 
medication compliance and patient compliance.
For the selection of articles included in the review 
the following databases were consulted: Medical 
Literature Analysis and Retrieval System Online 
Database Controlled Descriptors Non-controlled descriptors
Medline/
PubMed
Liver transplantation Hepatic transplantation
Medication adherence Liver orthotopic transplantation
Medication compliance Medication non-adherence
Patient compliance
CINAHL
(Ebsco)
Liver transplantation Hepatic transplantation
Medication compliance Liver orthotopic transplantation
Patient compliance Medication adherence
Medication non-adherence
LILACS
Liver transplantation Hepatic transplantation
Medication adherence Liver orthotopic transplantation
Patient compliance Medication non-adherence
Medication compliance
Scopus e Embase
Liver transplantation Hepatic transplantation
Medication adherence Liver orthotopic transplantation
Medication compliance Medication non-adherence
Patient compliance
Figure 2 – Controlled and non-controlled descriptors used for the review by each searched database. Sao Paulo, 2015 
It is worth noting that several combinations among 
the descriptors cited previously were performed in order 
to ensure the maximum scope of search.
The next figure describes the search process 
(Figure 3).
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Figure 3 - Diagram of inclusion and exclusion of articles available in the researched databases. Sao Paulo, 2015
Level Strength of evidence
I Evidences of synthesis of cohort or case-control 
studies.
II Evidences of a single cohort or case-control study.
III Evidences of meta-synthesis of qualitative or 
descriptive studies.
IV Evidences of a single qualitative or descriptive 
study.
V Evidences elicited from specialists opinions 
Source: Melnyk, B.M. & Fineout-Overholt, E. (2014). Evidence-based 
practice in nursing and healthcare: A guide to best practice.3ª ed. USA: 
Wolters Kluwer (14)
Figure 4 – Classification of the strength of evidence for 
clinical questions for prognosis or prediction 
The search returned 191 articles in the databases 
selected for this study. Initially, we proceeded to read 
the titles and abstracts, checking the adequacy of the 
analyzed studies compared with the proposed inclusion 
criteria in this study. Of these, 30 records were excluded 
for being duplicates, 119 per inadequacy to the subject 
of the review, 20 included subjects under 18 years of 
age and 12 included patients undergoing multiple organ 
transplants.
The extraction of data items included was performed 
with the aid of a validated instrument(13). For the analysis 
of the research study design and level of evidence it was 
used concepts proposed by Melnyk, Fineout-Overholt 
for clinical questions related to prognosis or prediction 
(Figure 4)(14).
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Results
Replies to the proposed inclusion criteria 10 articles, 
published between 2005 and 2013, highlighting the year 
2013 with four (40%) of these publications. Among 
the journals, Clinical Transplantation (30%) with three 
published investigations, Transplantation Proceedings 
with two (20%) and Transplant International, with two 
(20%) were the main sources.
All included investigations were published in the 
English language, nine of them (90%), written by 
medical professionals. As for the origin, five of them 
(50%) were produced in North America and five (50%) 
in European countries.
As for the strength of the evidence of the studies 
revealed that nine (90%) articles were classified as 
level two evidence, that is, cohort studies and one of 
the researches (10%) was considered at the level four 
evidence, a cross-sectional study.
In order to facilitate the understanding of the 
highlighted results, the investigations included in 
this review were grouped together into categories, 
namely: educational process and the occurrence of non-
compliance; non-adherence related to the number of 
daily doses of immunosuppressive medications; detection 
methods of non-adherence to immunosuppressive 
therapy and medication side effects related to non-
adherence to immunosuppressive therapy (Figure 5).
Category: Educational Process and occurrence of non-adherence
Author, journal and year Study design and sample (n) Objectives Main results and conclusions 
Strength of the 
evidence
Rodrigue et al. Progress in 
Transplantation, 2013(5)
R e t r o s p e c t i v e 
cohort
(236)
To evaluate if socio-
demographic and 
psychosocial factors previous 
to transplantation were 
predictive of non-adherence 
after the liver transplant.
The authors verified the fact that male 
subjects with unstable social support 
and mood disturbs may have more 
trouble in adhere to therapeutic regime. 
The lack of lists of patients with recurrent 
adhesion problems was also considered 
a risk factor.
II
Annunziato et al. The Journal 
of paediatrics, 2013(15)
Prospective cohort
(20)
To compare the impact of the 
presence of a care coordinator 
during transitioning between a 
pediatric to an adult service 
of two recipients of liver 
transplant vs. an historic 
group.
The group that had all the information 
to access the care coordinator, as well 
as the one that received the standard 
information, had higher serum level 
of the drug when compared with 
those that were transferred using a 
conventional routine In this respect, the 
authors suggest that using a reference 
person during transfers may raise the 
adherence to immunosuppressant 
therapy. 
II
Lamba et al. Clinical 
transplantation, 2012(8)
C r o s s - s e c t i o n a l 
study
(281)
To identify patients with 
higher risk of non-adherence 
among subjects having liver 
transplant.
The study detected a rate of 9,2 cases 
of non-adherence/100 transplants. 
Reasons for non-adherence: lack of 
information and diversity of used drugs. 
Risk subgroups for non-adherence: 
divorced, mental illness, alcohol and 
other substance users. 
IV
Category: Non-adherence related to number of daily doses of immunosuppressant medicines
Eberlin et al. Transplantation 
proceedings, 2013(16)
Prospective cohort
(65)
To compare the adherence 
rates between liver 
transplanted patients when 
they changed posology of 
Tacrolimus from twice a day 
to once a day.
The adherence rate did not change 
significantly in time after transplantation 
however the adherence was higher with 
the single dose.
II
Beckebaum et al. 
Transplantation international, 
2011(18)
Prospective cohort
(125)
To determine the efficacy, 
safety and adherence to
It was confirmed that the non-adhesion 
went from 66,4% down to 30,9% when 
posology changed from twice a day to 
a single daily dose. Serum levels of 
the drug were stabilized at the initial 
weeks of treatment without renal, liver 
or cardiac complications. 
II
(the Figure 5 continue in the next page...)
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Category: Educational Process and occurrence of non-adherence
Author, journal and year Study design and sample (n) Objectives Main results and conclusions 
Strength of the 
evidence
Category: Methods for detection of non-adherence to immunosuppressant therapy
Dopazo et al. Clinical 
Transplantation, 2012 (17)
Prospective cohort
(187)
To evaluate safety and 
efficacy in conversion from 
Tacrolimus twice a day to a 
single daily dose in adults 
undergoing liver transplant.
The study corroborates that this model 
is safe, as six months after posology 
change, reducing from two doses a 
day to a single dose, the serum level of 
the drug was stable at the same level 
as previous without hepatic or renal 
function alterations.
II
Lieber et al. Transplantation 
proceedings, 2013(19)
R e t r o s p e c t i v e 
cohort
(566)
To compare the performance 
of three different methods of 
verification of non-adherence.
The largest rate of non-adherence 
was measured by a self-responded 
questionnaire; however, the authors 
suggest that the serum level dosage of 
Tacrolimus is a useful test for detection 
of non-adherence. 
II
Park et al. Journal of the 
American Medical Informatics 
Association, 2010(20)
R e t r o s p e c t i v e 
cohort
(127)
To research if a clinical man-
agement system may improve 
the outcomes in the clinical 
management of adherence to 
immunosuppressant among 
transplant recipients.
Patients with software follow-up had 
less rejection events and toxicity to 
Tacrolimus. The recurring costs of the 
computational system was ten times 
less than the wages of the staff needed 
to fill out the follow-up forms. The use of 
a clinical management system showed 
a lower rate of non-adherence and 
organ rejection.  
II
Drent et al. Transplant 
International, 2005(21)
Prospective cohort
(108)
To evaluate the non-
adherence to prednisolone 
among 108 adults receiving a 
liver graft, through electronic 
monitoring of the event.
Roll out of an electronic system in the 
medicine’s cap recording date, opening 
and closing time of a group of patients. It 
was proved that adherence was higher 
with this system and patients over 
40 years had more risks in delaying 
medication intake.
II
Category: Side effects of dr'ugs related to non-adherence to immunosuppressant therapy
Drent et al. Clinical 
Transplantation, 2008(3)
Prospective cohort
(123)
To evaluate the long-term 
symptoms experienced 
by adults undergoing liver 
transplant.
No correlation was found between 
the symptoms experienced by trans-
planted patients and non-adherence to 
treatment. The side effects were more 
serious for women than for men, e.g. 
widespread pain. Men referred sexual 
malfunction.
II
Figure 5 – Display of articles following analysis categories, year of publication, journal, objectives, main results and 
conclusions. Sao Paulo, Brazil, 2015.
Discussion
The selected studies on the issue of non-adherence 
to immunosuppressive therapy in patients undergoing 
liver transplantation were produced predominantly in 
North America and Europe.
Another fact of equal relevance refers to the 
absence of studies by nursing professionals, since 90% 
of the articles included are the results of research carried 
out by professionals from other fields of knowledge. 
Regarding the methodological design, the majority of 
the sample consisted of cohort studies, a design that 
leads to difficulties in controlling bias(22).
It is recognized that the best evidence is obtained by 
means of high quality methodological studies, allowing 
the generalization of the research results and also 
gathering information capable of providing support for 
clinical decision making, such as randomized controlled 
trials. However, it is noteworthy that the cohort studies 
are typically used to evaluate results of risk exposure(23). 
Thus, this may be one of the designs recommended for 
research and evaluate risk factors for non-adherence to 
immunosuppressive therapy.
Therefore, the data found in different studies 
included in the present IR were synthesized into 
categories, the first one refers to the “Educational 
process and the occurrence of non-adherence” where 
the risk factors for non-adherence were of two kinds: 
related to the therapeutic process, such as lack of 
information on the treatment and the use of various 
drugs; and related to the individual, such as being 
male, alcohol users or other substances, exposed to 
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lower or unstable social support and those with mental 
illnesses(5,8,15). The strategies adopted among the studies 
included in this category suggest the optimization of 
the teaching-learning process, through the inclusion of 
family members training them in the use of drugs in the 
preoperative period(5). In addition, direct contact with a 
professional responsible for the clinical follow-up seems 
to have a consequence in better adherence rates(15).
Also noteworthy are the risk factors related to 
the organization of health services, such as the lack of 
records of patients with persistent compliance problems, 
since the formal ignorance of these subjects may result 
in inadequate planning of educational activities(5).
Another category was “non-adherence related to 
the number of daily doses of immunosuppressive drugs,” 
which addressed the adherence difficulties caused by the 
use of several drugs simultaneously. The intervention 
studied in this group of papers was the change in 
posology, from twice a day, for a daily single dose. The 
three studies included, found significant reduction of 
non-adherence, stabilization of serum drug levels and 
absence of liver, renal and cardiac complications(16-18).
In the category “Methods of detection of non-
adherence to immunosuppressive therapy,” it was noted 
that putting in place surveillance methods for adherence, 
interferes in patients’ response to drug therapy and 
therefore result in better outcomes of transplantation. 
However, there is no consensus regarding the best 
method for measurement of non-compliance; and 
three studies(19-21) suggest that the self-administered 
questionnaire resulted in the measurement of the 
higher rate of non-compliance; another suggested tool 
is the implementation of a computer program for 
monitoring the use of medicines(20), when associated 
with the assistance of health professionals, resulted 
in fewer rejection and intoxication events  by the 
immunosuppressant drug. Another suggested method 
is an electronic device installed on the caps of the vials 
of drugs that would be able to detect the time of its 
opening and its closing(19-21).
The last category was composed of a single work 
and refers to the evaluation of side effects related to 
immunosuppressive therapy as a risk factor for non-
adherence(3). This study found that the most serious side 
effects were widespread pain among female subjects, 
and among men sexual dysfunction, however, there was 
no correlation between symptoms perceived by patients 
and the phenomenon of non-adherence(3).
Patients undergoing liver transplantation are 
patients with chronic diseases and require the constant 
use of drugs, with risks and health problems, making 
it imperative for them to be able to understand the 
importance of the procedure; learn to deal with the 
drugs; change hygiene habits, with the aim of combating 
infectious processes and adapt to various changes, such 
as the self-image, and social issues, such as work, for 
instance(11).
In this sense, and due to the complexity in the 
treatment guidance, it was developed the “Guideline 
for evaluation of the indication of liver transplant” of 
the Association for the Study of Liver Disease and the 
American Transplant Society, which indicates the need, 
during the evaluation period of the indication of the 
transplant, to conduct meetings for patients and family 
education about all aspects involved in the procedure 
and even on adherence to immunosuppressive 
medications(1).
In the research that evaluated 370 subjects 
undergoing transplants in France, 135 were liver 
transplant recipients and among them, it was found that 
51% of subjects had non-adherence to treatment. It was 
stated also that the simplification of drugs protocols can 
increase compliance, because patients have difficulties 
in dealing with the treatment(24).
In research(25), which measured knowledge 
before and after the educational intervention among 
candidates to liver graft, it was found that despite the 
intervention contemplated the perioperative period, 
the understanding of the information related to the 
pre-operative period was higher compared to the post-
operative(25).
Another study sought to evaluate the effectiveness 
of the guidelines conducted by a multidisciplinary 
group for patients in the pre-operative period of 
liver transplantation, including 53 patients and 60 
companions, showing that after the meetings of the 
educational group, there was an increase in the number 
of right answers in almost all areas covered, and the 
item with the highest increase in the number of correct 
answers was related to the use of immunosuppressive 
drugs(26).
Several factors have been associated with behaviors 
of non-compliance, ranging from health problems such 
as depression(27), to questions related to social status 
or associated with intrinsic characteristics of patients, 
such as being male, with low social support(5), or related 
to the health system, such as the lack or absence of 
available medication(9). This last factor in particular, 
does not apply in theory to Brazil, since health care is 
provided for in the Constitution of 1988, which states 
that health “is everyone’s right and duty of the state”, 
therefore immunosuppressive drugs are offered by the 
Brazilian National Health System (SUS)(28).
Another aspect that may contribute to non-
adherence are the side effects, which seem to cause 
more discomfort among women than among men, 
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ranging from widespread pain, more commonly reported 
by women, to sexual dysfunction (in men)(3). Studies 
including patients with the human immunodeficiency 
virus (HIV), found that the absence of side effects is a 
protective factor for non-adherence to medication(29-30).
The reduction in the dosage of immunosuppressant 
to a single daily dose is considered as a measure 
that confirms the reduction of the problem of 
non-compliance(17-19), an aspect pointed out by 
studies, showed reduction of non-adherence to 
immunosuppressive therapy when there was an 
increase in dose and a reduction in dosage for a single 
daily dose. Other research developed involving subjects 
with chronic non-communicable diseases have shown 
that the reduction in the number of drug doses, and the 
dosage corresponding to the routine of patients resulting 
in increased adherence to therapy(31-32).
Many methods can contribute to the detection of 
non-adherence to immunosuppressive therapy, from 
self-completed questionnaires, measurement of serum 
drug level and use of electronic systems that are able 
to detect the opening and closing of medicine bottles, 
generating reports to health professionals who monitor 
the patients(16,20).
There is no consensus regarding the best method 
of assessment of non-compliance. Probably this actually 
happens since it is a multidimensional phenomenon, 
and for this reason should be evaluated in various ways, 
including the use of technology(30,33-35).
Therefore, it is remarked the importance of 
guidance, through health education in relation to 
adherence to immunosuppressive therapy. Thus, we 
highlight the role of the nurse in the development of 
these activities, promoting safe behavior and the use 
of mechanisms that favor adherence in relation to 
immunosuppressive drugs.
It is believed that the issues brought to light in this 
study are able to guide the decision making process 
of nurses and health professionals in order to map 
out and know which patients are more prone to non-
adherence, suggesting strategies to better monitoring 
and increasing adherence to therapy, but ultimately 
preventing and reducing the episodes of rejection, re-
hospitalization and especially damage to the health and 
quality of life of the patients(25).
Conclusion
It was concluded that the risk factors for non-
adherence to immunosuppressive medications among 
adult patients undergoing liver transplantation, pointed 
out by the analyzed scientific literature are of two kinds: 
those related to health services, characterized by the 
absence of lists for customized monitoring of patients 
which are not adherent, no clear methodology enabling 
the classification of patients into adherent and non-
adherent groups and personal risk factors evidenced by 
problems or lack of social support, lack of information, 
simultaneous use of several drugs, diagnosis of mental 
illness, alcohol and other drugs use and being male.
The literature also points out, as protective factors 
for the phenomenon of non-adherence, the follow-up 
by the family in therapeutic encounters that provide 
health education; receiving standardized information; 
direct contact with the adequate type of professional, 
responsible for the clinical monitoring of the patient and 
a reduction of the dose to once daily.
Limitations of this study include the lack of 
investigations with greater methodological rigor and 
allowing larger comparisons and extrapolation of the 
results.
There was also remarkable the absence of national 
articles on the theme, indicating a field to be explored 
by the Brazilian scientific literature, as it becomes 
interesting to know what are the factors that impact 
on adherence to immunosuppressive therapy among 
Brazilian patients since the health care organization in 
Brazil differs from countries whose papers were included 
in this review.
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